Lenalid 25 Mg (Lenalidomide)

Description

What Is Lenalid 25 Mg? Lenalid 25 Mg is an oral medicine containing lenalidomide 25 mg, an immunomodulatory drug used in the treatment of certain blood-related cancers and disorders. It is prescribed for conditions such as multiple myeloma and myelodysplastic syndromes (MDS) and can also have a role in the treatment of mantle cell lymphoma and certain leprosy-associated complications. Manufactured by Natco Pharma Ltd., Lenalid 25 Mg is available as a prescription medicine. Its use, dosage, and treatment duration are determined according to the condition being treated, overall health, kidney function, and other medicines or therapies being received. Lenalid 25 Mg Uses Lenalidomide 25 mg is prescribed for particular patients with: Multiple myeloma, usually in combination with dexamethasone Relapsed or progressed mantle cell lymphoma after specified previous treatments Selected cases of follicular lymphoma when used with a rituximab product Selected cases of marginal zone lymphoma when used with a rituximab product Lenalidomide is also approved for certain patients with transfusion-dependent anemia caused by low- or intermediate-1-risk myelodysplastic syndromes associated with a deletion 5q abnormality. The appropriate indication depends on the patient’s diagnosis and treatment history. How Does Lenalid 25 Mg Work? Lenalidomide affects immune-system activity and interferes with processes that support the growth and survival of abnormal blood cells. Its effects can vary according to the disease being treated and the accompanying medicines. For multiple myeloma, lenalidomide is commonly combined with dexamethasone. It may also be used as maintenance treatment after autologous stem cell transplantation, although that maintenance regimen generally uses a different starting strength. How to Take Lenalid 25 Mg Take Lenalid 25 Mg exactly as prescribed. Take the capsule at approximately the same time each day. It can generally be taken with or without food. Swallow the capsule whole with water. Do not crush, open, or chew the capsule. Do not take an extra capsule to compensate for a missed dose unless specifically instructed. Never share lenalidomide with another person. The prescribing information recommends swallowing the capsule whole, and handling damaged capsules requires particular care because the medication can be harmful if it comes into contact with the skin. Remember: Lenalid 25 Mg treatment should be followed according to the prescribed schedule, and any changes in dose or treatment cycle should be made only as directed by the treating doctor. Lenalid 25 Mg Benefits The potential treatment benefits of Lenalid 25 Mg are related to its established role in selected hematologic cancers and bone marrow disorders. Provides an oral lenalidomide treatment option Forms part of combination therapy for multiple myeloma Has an established role in selected lymphoma treatment regimens Can be used in specific myelodysplastic syndrome cases Can be incorporated into long-term treatment plans when prescribed by an oncology specialist The expected benefit depends on the diagnosis, treatment combination, disease stage, and individual response. Lenalid 25 Mg Dosage Guide The appropriate dose of Lenalid 25 Mg depends on the condition being treated and factors such as kidney function, blood counts, age, and other medicines being taken. Lenalidomide should be taken exactly as prescribed, as the treatment schedule can vary between patients. Missed Dose If you forget to take Lenalid 25 Mg, the missed dose can generally be taken if less than 12 hours have passed since your usual dosing time. If more than 12 hours have passed, skip the missed dose and take the next dose at the regular time. Do not take two doses together to make up for a missed dose. Lenalid 25 Mg Overdose Taking more Lenalid 25 Mg than prescribed can increase the risk of serious adverse effects. If you accidentally take an excessive amount, contact your doctor or seek immediate medical assistance rather than taking any further doses on your own. There is no specific antidote for lenalidomide overdose; treatment is generally supportive. Lenalid 25 Mg Side Effects Possible Lenalid 25 Mg side effects can vary depending on the condition being treated and other medicines used alongside it. Commonly reported effects include: Fatigue or weakness Diarrhea or constipation Nausea Anemia Low white blood cell counts Low platelet counts Muscle cramps Rash Cough or upper respiratory infections Fever Dizziness Swelling of the limbs Lenalidomide can also cause more serious problems, including significant reductions in blood-cell counts and blood clots. Serious Reactions Requiring Prompt Medical Attention Contact a healthcare professional promptly for symptoms such as: Unusual bleeding or bruising Persistent fever or signs of infection Sudden shortness of breath Chest pain Painful or swollen arm or leg Severe rash or skin peeling Symptoms suggesting a serious allergic reaction Lenalidomide has important warnings concerning blood-count abnormalities and venous or arterial thromboembolic events. Lenalid 25 Mg Drug Interactions Lenalidomide can interact with medicines or treatments that affect blood clotting, blood-cell levels, or other aspects of treatment. Medicine / Treatment Possible concern Digoxin Lenalidomide increases digoxin exposure; monitoring may be required Erythropoietin-stimulating agents Can contribute to increased thrombotic risk Estrogen-containing therapies Can increase the risk of blood clots Medicines affecting blood clotting The overall bleeding or clotting risk needs assessment Other anticancer medicines Combined treatment can alter blood counts and tolerability Always provide the complete list of medicines, supplements, and ongoing treatments before starting lenalidomide. Remember: Keep a complete record of your current medicines and treatments, as this can help identify potential issues when your treatment plan is reviewed. Lenalid 25 Mg Precautions and Warnings Lenalidomide requires careful monitoring because it can affect blood counts and increase the risk of blood clots. Pregnancy Lenalidomide can cause severe, life-threatening birth defects or fetal death. It must not be used during pregnancy. Pregnancy-prevention requirements apply to patients who can become pregnant and to male patients who may father a child. Blood Counts Treatment can cause neutropenia, thrombocytopenia, anemia, and other changes in blood-cell counts. Regular blood tests are generally required during treatment. Kidney Function Lenalidomide is substantially eliminated through the kidneys. Patients with reduced kidney function may require a lower starting dose or other dosage adjustment. Blood Clots Lenalidomide, particularly when used with dexamethasone in multiple myeloma, can increase the risk of deep vein thrombosis, pulmonary embolism, heart attack, and stroke. The need for preventive antithrombotic treatment should be assessed by the treating clinician. Lenalid 25 Mg Storage Store Lenalid 25 Mg at room temperature in a dry place, away from direct sunlight, excessive heat, and moisture. Keep the capsules out of the reach of children and pets, and do not use them if they are damaged or expired.